The actual device was not available; however, photographs and video of the sample were provided for evaluation.Visual inspection of the pictures and video showed a blood leak at the level of the anticoagulant line.The reported condition was verified.It was reported that flolan was used as an anticoagulant.Flolan is not an anticoagulant, it is a drug that prevents platelet aggregation.The instructions for use give instructions regarding the "anticoagulation line", so the flolan should not be injected from the anticoagulant line.Flolan is incompatible with the prismaflex sets because they do not contain pet but contain some polyethylene terephthalate glycol components.This is an abnormal use by the operator or user.Based on available information, it is unlikely that a malfunction of the prismaflex st150 set caused or contributed to the reported event of blood loss.The cause of the condition was due to user error.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
|